DOCSLIB.ORG

Quest Diagnostics, Inc. Account Setup

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Quest Diagnostics, Inc. Account Setup Our Lab Service Provider is To Become A Member Quest Diagnostics, Inc. Account Setup Test Code Test Name Retail Test Code Test Name Retail 10611 A PHAG AND E CHEF AB $ 105.00 334 CHOLESTEROL, TOTAL $ 4.00 785 ABO GROUP $ 6.40 4451 CK ISOENZYME PANEL $ 42.00 7788 ABO GRP AND RH TYPE $ 12.80 377 CK ISOENZYMES $ 36.80 208 ACID PHOS, PROS, IMM $ 11.20 374 CK, TOTAL $ 5.20 211 ACTH $ 24.00 35555 CMP W/O ALT $ 8.78 237 AFP,TUMOR (CHIRON) $ 22.40 34389 CMP W/O CO2,ALT $ 8.48 223 ALBUMIN $ 4.24 6732 CMV IGG & IGM AB $ 49.60 227 ALDOLASE $ 11.20 403 CMV IGG AB $ 24.00 231 ALK PHOS ISOENZYMES $ 32.00 8503 CMV IGM AB $ 25.60 234 ALKALINE PHOSPHATASE $ 4.24 19826 COENZYME Q10 $ 35.20 823 ALT $ 5.30 36167 COLLAGEN CROSS-LINK $ 56.00 5509 AMMONIA (P) $ 48.00 17406 COLLAGEN TYPE I CTX $ 45.00 243 AMYLASE $ 8.00 10231 COMP METAB PNL $ 11.00 249 ANA W/RFX $ 30.00 90839 COMP METAB PNL, PLASMA $ 7.26 255 ANTI-DSDNA AB, EIA $ 30.40 90840 COMP METAB W/ADJ CAL PLS $ 7.26 16842 ANTI-MULLERIAN $ 47.25 351 COMPLEMENT C3C $ 19.20 5223 APOLIPOPROTEIN A1 $ 25.00 353 COMPLEMENT C4C $ 19.20 5224 APOLIPOPROTEIN B $ 16.00 363 COPPER $ 33.32 7018 APOLIPOPROTEIN EVAL $ 50.00 19081 CORD BLOOD ABO/RH $ 12.80 10295 ASCA IGA $ 32.00 38149 CORTISOL BASELINE $ 12.80 10294 ASCA IGG $ 32.00 6738 CORTISOL, 2 SPEC $ 25.60 265 ASO $ 22.40 7303 CORTISOL, 3 SPEC $ 38.40 822 AST $ 5.30 6736 CORTISOL, 4 SPEC $ 51.20 34300 BABESIA MICROTI IGG/IGM $ 36.38 6735 CORTISOL, 5 SPEC $ 64.00 10165 BASIC METAB PNL $ 7.28 6734 CORTISOL, 6 SPEC $ 76.80 34388 BASIC METAB PNL W/O CA $ 5.57 4212 CORTISOL, A.M. $ 16.00 90841 BASIC METAB PNL, PLASMA $ 5.82 37077 CORTISOL, FREE-TOTAL $ 48.57 287 BILIRUBIN, TOTAL $ 4.24 4213 CORTISOL, P.M. $ 12.80 285 BILIRUBIN,DIRECT $ 4.24 367 CORTISOL, TOTAL $ 16.00 7286 BILIRUBIN,FRAC. $ 4.37 372 C-PEPTIDE $ 24.00 37386 BNP $ 80.00 375 CREATININE $ 4.24 296 BUN/CREAT RATIO $ 4.37 381 CREATININE (U) $ 8.00 16898 BV DNA, QNT REAL-TIME PCR $ 150.00 8459 CREATININE RAND (U) $ 8.00 30440 C.ALBICANS IGG/A/M $ 60.00 4420 CRP $ 12.00 5819 CA 15-3 $ 25.60 10570 CYSTAIN C $ 28.80 4698 CA 19-9 (CENTOCOR) $ 24.00 8659 D-DIMER QN $ 120.00 29256 CA125 $ 27.20 402 DHEA-SULFATE $ 36.00 29493 CA27.29 CHIRON/BAYER $ 24.00 19765 DIABETIC PROFILE $ 31.04 30742 CALCITONIN $ 48.00 90567 DIHYDROTESTOSTERONE $ 50.00 303 CALCIUM $ 4.24 8293 DIRECT LDL $ 26.00 306 CALCIUM, IONIZED $ 33.60 6421 EBV AB PANEL $ 99.00 310 CARBON DIOXIDE $ 4.24 15447 EBV EARLY AG D IGG $ 24.00 91724 CARDIO IQ(TM) APO A1 $ 25.00 8474 EBV IGG AB $ 32.00 91726 CARDIO IQ(TM) APO B $ 16.00 8426 EBV IGM AB $ 24.00 91727 CARDIO IQ(TM) APO EVAL $ 50.00 8564 EBV NUCLEAR AG AB $ 32.00 91717 CARDIO IQ(TM) CHOL TOT $ 3.20 37914 ECP $ 75.00 91723 CARDIO IQ(TM) DIRECT LDL $ 20.80 34271 EHRLICHIA CHAF AB $ 45.00 91719 CARDIO IQ(TM) HDL CHOL $ 3.20 34392 ELECTROLYTE PANEL $ 4.85 91732 CARDIO IQ(TM) HGB A1C $ 6.40 427 ERYTHROPOIETIN $ 48.00 91737 CARDIO IQ(TM) HS-CRP $ 12.80 4021 ESTRADIOL $ 24.00 91731 CARDIO IQ(TM) INSULIN $ 10.40 30289 ESTRADIOL,EXTRACTION $ 41.99 91729 CARDIO IQ(TM) LP (A) $ 26.32 34883 ESTRIOL,SERUM $ 35.20 91738 CARDIO IQ(TM) LP-PLA2 $ 41.60 439 ESTROGEN, TOTAL (S) $ 61.00 91739 CARDIO IQ(TM) NT-PROBNP $ 99.20 23244 ESTRONE $ 32.00 91718 CARDIO IQ(TM) TRIGLYC. $ 3.84 11290 FECAL IMMUNOCHEM $ 32.00 91716 CARDIO IQ(TM)LIPID PANEL $ 12.80 11293 FECAL IMMUNOCHEM MED $ 32.00 91604 CARDIO IQ(TM)LIPO,ION MOB $ 40.00 457 FERRITIN $ 7.00 6399 CBC (DIFF/PLT) $ 8.00 461 FIBRINOGEN QN $ 20.00 1759 CBC(H/H,RBC,WBC,PLT) $ 6.70 467 FOLATE, RBC $ 25.60 11173 CCP AB IGG $ 49.60 466 FOLATE,SERUM $ 12.00 978 CEA $ 16.00 8340 FRUCTOSAMINE $ 9.92 326 CERULOPLASMIN $ 20.00 470 FSH $ 12.80 37126 CHLAMYDIA AB PNL 2 $ 44.15 7137 FSH & LH (S) $ 32.00 11363 CHLAMYDIA/GC RNA,TMA $ 48.00 4112 FTA-ABS $ 16.00 330 CHLORIDE $ 4.24 34878 GAD-65 AB $ 72.00 Prices are subject to change without notice. 20180301 ©2018 OptionOne Lab. All Rights Reserved. 1/5 15114 GAST,PARIETAL CELL AB $ 32.00 37669 IGA,IGG,IGM IMMUNOF $ 94.40 478 GASTRIN $ 20.80 16293 IGF I, ECL $ 50.00 6726 GASTRIN, 2 SPEC $ 41.60 34458 IGFBP-3 $ 26.25 6725 GASTRIN, 3 SPEC $ 62.40 7903 IGG SUBCLASS PANEL $ 112.50 6724 GASTRIN, 4 SPEC $ 83.20 15435 IMMUNE CELL FUNCTION $ 225.00 6723 GASTRIN, 5 SPEC $ 104.00 549 IMMUNOFIXATION, SERUM $ 48.00 6722 GASTRIN, 6 SPEC $ 124.80 539 IMMUNOGLOBULIN A $ 9.60 6721 GASTRIN, 7 SPEC $ 145.60 542 IMMUNOGLOBULIN E $ 13.60 482 GGT $ 4.00 543 IMMUNOGLOBULIN G $ 10.40 7470 GH, 10 SPEC $ 400.00 545 IMMUNOGLOBULIN M $ 10.40 7462 GH, 2 SPEC $ 80.00 7083 IMMUNOGLOBULINS $ 30.40 7464 GH, 4 SPEC $ 160.00 669 INDICAN $ 14.40 7467 GH, 7 SPEC $ 280.00 561 INSULIN $ 11.00 11212 GLIADIN AB IGG $ 32.00 36178 INSULIN ABS, HIGHLY $ 57.60 8889 GLIADIN AB IGG/IGA $ 64.00 6697 INSULIN, 2 SPEC $ 20.80 11228 GLIADIN IGA $ 32.00 6695 INSULIN, 3 SPEC $ 31.20 1430 GLUC GEST & FAST-135 $ 9.60 6694 INSULIN, 4 SPEC $ 41.60 19834 GLUC GEST & FAST-140 $ 9.60 6693 INSULIN, 5 SPEC $ 52.00 8477 GLUC, GEST SCRN -135 $ 4.80 6691 INSULIN, 6 SPEC $ 62.40 19833 GLUC, GEST SCRN 140 $ 4.80 6690 INSULIN, 7 SPEC $ 72.80 4312 GLUC,FAST & POST 1HR $ 9.60 6689 INSULIN, 8 SPEC $ 83.20 6881 GLUC,FAST & POST 2HR $ 9.60 6688 INSULIN, 9 SPEC $ 93.60 5722 GLUCOSE PP (75 GRAM) $ 4.80 568 INTRINSIC FACTOR AB $ 40.00 484 GLUCOSE, PLASMA $ 4.80 16599 IODINE SERUM,PLASMA $ 30.00 8476 GLUCOSE, PP/1 HR $ 4.80 571 IRON, TOTAL $ 4.00 4637 GLUCOSE, PP/2 HOUR $ 4.80 7573 IRON, TOTAL, & IBC $ 7.76 483 GLUCOSE, SERUM $ 4.24 7675 LACTOSE, 5 SPEC 50G $ 24.00 35181 GTT, 2 SPEC $ 9.60 597 LD ISOENZYMES $ 40.00 23475 GTT, 3 SPECIMENS $ 14.40 593 LDH, TOTAL $ 4.00 6745 GTT, GESTATIONAL, 4 $ 19.20 599 LEAD, (B) $ 32.00 10559 GTT,4 SPECIMEN $ 19.20 90367 LEPTIN $ 50.00 10560 GTT,5 SPECIMEN $ 24.00 615 LH $ 12.80 10562 GTT,6 SPECIMEN $ 28.80 4571 LH - 5 SPEC $ 64.00 10563 GTT,7 SPECIMEN $ 33.60 606 LIPASE $ 11.20 18927 GTT,GEST,3 IADPSG $ 14.40 7600 LIPID PANEL $ 12.50 34838 H.PYLORI AG STOOL $ 128.00 19543 LIPID PANEL WITH RATIOS $ 12.80 14839 H.PYLORI BREATH TEST $ 104.00 34604 LIPOPROTEIN (A) $ 26.32 8435 HCG TOTAL QL $ 20.00 613 LITHIUM $ 19.20 8396 HCG, TOTAL, QN $ 12.00 14530 LP-PLA2 (PLAC R ) $ 41.60 608 HDL-CHOLESTEROL $ 4.00 29477 LYME DIS IGG WBA $ 55.34 509 HEMATOCRIT $ 5.04 8593 LYME DIS IGG/IGM WBA $ 40.00 510 HEMOGLOBIN (B) $ 5.04 7197 LYMPH SUBSET PNL 1 $ 105.00 496 HEMOGLOBIN A1C $ 10.00 7924 LYMPH SUBSET PNL 4 $ 80.00 16802 HEMOGLOBIN A1C W/EAG $ 8.00 659 M PNEUMO IGG AB $ 25.60 8181 HEMOGLOBIN A1C W/MPG $ 6.40 21130 M. PNEUM IGM AB $ 48.00 7008 HEMOGRAM $ 5.28 34127 M.PNEUM IGG/IGM $ 73.60 7210 HEMOGRAM & DIFF $ 5.36 622 MAGNESIUM $ 8.00 512 HEP A IGM AB $ 22.40 623 MAGNESIUM, RBC $ 29.00 4848 HEP B CORE IGM AB $ 24.00 6517 MALB, RAND UR W/CR $ 17.60 499 HEP B SURF AB QL $ 16.80 17674 MALB, RAND UR W/O CR $ 9.60 498 HEP B SURF AG W/CONF $ 12.80 34879 METHYLMALONIC ACID $ 72.00 10256 HEPATIC FUNC PNL $ 6.96 91032 METHYLMALONIC ACID U $ 32.00 34391 HEPATIC FUNC PNL W/O TP $ 5.33 4555 MICROALBUMIN 24HR (U) $ 9.60 90842 HEPATIC FUNC PNL, PLASMA $ 5.57 8280 MICROALBUMIN, TIMED (U) $ 9.60 654 HETEROPHILE, MONO $ 11.20 8922 MIXING STUDY $ 48.00 7998 HGB & HCT $ 5.12 17911 MTHFR, DNA MUTATION $ 80.00 521 HGH $ 40.00 34184 NK CELL FUNCTION $ 120.00 7463 HGH, 3 SPEC $ 120.00 91734 OMEGA3/6 FATTY ACIDS $ 48.00 7465 HGH, 5 SPEC $ 200.00 6653 OVA & PARASITE X2 $ 48.00 7466 HGH, 6 SPEC $ 240.00 6652 OVA & PARASITE X3 $ 72.00 7468 HGH, 8 SPEC $ 320.00 681 OVA AND PARASITE $ 24.00 7469 HGH, 9 SPEC $ 360.00 11368 PAI-1 4G/5G $ 75.00 34282 HHV 6 AB PNL $ 68.80 718 PHOSPHATE (AS PHOS) $ 4.24 16185 HIV 1 RNA, QL TMA $ 180.00 723 PLATELET COUNT $ 5.04 15584 HLA-B27 $ 112.00 733 POTASSIUM $ 4.24 31789 HOMOCYSTEINE $ 41.00 11014 POTASSIUM,PLASMA $ 4.24 91733 HOMOCYSTEINE,CARDIO $ 32.00 31493 PREGNENOLONE LC/MS/MS $ 100.00 10124 HS CRP $ 16.00 8847 PRO TIME WITH INR $ 6.50 Prices are subject to change without notice.
Load more

Recommended publications
  • Section 8: Hematology CHAPTER 47: ANEMIA
    Section 8: Hematology CHAPTER 47: ANEMIA Q.1. A 56-year-old man presents with symptoms of severe dyspnea on exertion and fatigue. His laboratory values are as follows: Hemoglobin 6.0 g/dL (normal: 12–15 g/dL) Hematocrit 18% (normal: 36%–46%) RBC count 2 million/L (normal: 4–5.2 million/L) Reticulocyte count 3% (normal: 0.5%–1.5%) Which of the following caused this man’s anemia? A. Decreased red cell production B. Increased red cell destruction C. Acute blood loss (hemorrhage) D. There is insufficient information to make a determination Answer: A. This man presents with anemia and an elevated reticulocyte count which seems to suggest a hemolytic process. His reticulocyte count, however, has not been corrected for the degree of anemia he displays. This can be done by calculating his corrected reticulocyte count ([3% × (18%/45%)] = 1.2%), which is less than 2 and thus suggestive of a hypoproliferative process (decreased red cell production). Q.2. A 25-year-old man with pancytopenia undergoes bone marrow aspiration and biopsy, which reveals profound hypocellularity and virtual absence of hematopoietic cells. Cytogenetic analysis of the bone marrow does not reveal any abnormalities. Despite red blood cell and platelet transfusions, his pancytopenia worsens. Histocompatibility testing of his only sister fails to reveal a match. What would be the most appropriate course of therapy? A. Antithymocyte globulin, cyclosporine, and prednisone B. Prednisone alone C. Supportive therapy with chronic blood and platelet transfusions only D. Methotrexate and prednisone E. Bone marrow transplant Answer: A. Although supportive care with transfusions is necessary for treating this patient with aplastic anemia, most cases are not self-limited.
    [Show full text]
  • Method Development and Validation of Vitamin D2 and Vitamin D3 Using Mass Spectrometry
    Method Development and Validation of Vitamin D2 and Vitamin D3 Using Mass Spectrometry Devon Victoria Riley A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science University of Washington 2016 Committee: Andrew Hoofnagle Geoffrey Baird Dina Greene Program Authorized to Offer Degree: Laboratory Medicine ©Copyright 2016 Devon V. Riley ii University of Washington Abstract Method Development and Validation of Vitamin D2 and Vitamin D3 Using Mass Spectrometry Devon V. Riley Chair of the Supervisory Committee: Associate Professor Andrew Hoofnagle, MD, PhD Vitamin D has long been known to maintain bone health by regulating calcium and phosphorous homeostasis. In recent years, scientists have discovered additional physiological roles for vitamin D. The complex interaction between the active vitamin D hormone and its metabolic precursors continues to be a rich area of research. Fundamental to this research is the availability of accurate and precise assays. Few published assays for vitamins D2 and D3 have contained sufficient details on method validation or performance characteristics. The liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay developed for this thesis has undergone a rigorous validation and proven to yield a sensitive and specific method that exceeds the capabilities of all previously published methods. Developing and validating a novel assay is often complicated by the lack of established acceptability standards. This thesis explores this challenge, specifically for establishing meaningful interpretations and qualification standards of the lower limit of the measuring interval. Altogether, future research focused on vitamins D2, D3 and the Vitamin D pathway can benefit from this robust LC-MS/MS assay and the associated quality parameters outlined in this thesis.
    [Show full text]
  • Evaluation of Prolonged Surface Activated Coagulation Time
    Biomedical Science Faculty of Health and Society Malm¨oUniversity SE-205 06 Malm¨o Sweden Master programme in Biomedical Surface Science http://edu.mah.se/en/Program/VABSE Evaluation of prolonged surface activated coagulation time Master degree thesis, 30 ECTS Author: Amalie Jesting Supervisors: Sebastian Bj¨orklund,PhD, Lecturer, Malm¨oUniversity Jens Peter Gøtze, MD, DMSc Professor, Chief-Physician, Rigshospitalet Søren Frank Jørgensen, MSc, Senior Lecturer, Metropolitan University College August 2018 MALMO¨ UNIVERSITY Abstract Faculty of Health and Society Master programme in Biomedical Surface Science Evaluation of prolonged surface activated coagulation time by Amalie Jesting Background: Blood coagulation is an essential defense mechanism to prevent bleeding. Disorders in the coagulation system can be severe and blood tests measuring the blood's ability to coagulate are important. Activated partial thromboplastin time (APTT) is a blood test that measures blood coagulation time. An abnormal prolonged APTT can both be associated with a bleeding tendency or a risk of thrombosis. Additional blood tests are needed to discover the cause of a prolonged APTT. One potential test is the APTT mixing study, which can separate samples with and without inhibitors. The aim of this project is to investigate how the cause of a prolonged APTT is evaluated today and to examine if it is possible to indicate the cause of a prolonged APTT using the APTT mixing study performed on routine samples. The goal is to be able to indicate the cause of a prolonged APTT immediately when is it first discovered. This will save time and help guide the physicians in their work with the patient.
    [Show full text]
  • A Life-Threatening Case of Pregnancy-Related Atypical
    Puri et al. BMC Nephrology (2020) 21:488 https://doi.org/10.1186/s12882-020-02100-4 CASE REPORT Open Access A life-threatening case of pregnancy- related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab Prianka Puri1,2* , Anida Hanxhiu1, Daniel V. O’Hara1,3, Danny Hsu4 and Mirna Vucak-Dzumhur1,5 Abstract Background: Pregnancy-related Atypical Haemolytic Uremic Syndrome (P-aHUS) is a rare condition affecting genetically predisposed women during pregnancy. It is often difficult to diagnose and has a significant impact on maternal and foetal outcomes. It is characterised by microangiopathic haemolytic anaemia and kidney injury from thrombotic microangiopathy. Case presentation: A 27-year-old female of Lebanese descent presented at 36 weeks’ gestation with foetal death in-utero (FDIU) with placental abruption on a background of previously normal antenatal visits. She was coagulopathic and anaemic with anuric acute kidney injury, requiring emergency Caesarean section, intubation and dialysis. Her coagulopathy rapidly resolved, however, her anaemia and renal dysfunction persisted. A diagnosis of P-aHUS was made, and she was empirically treated with Eculizumab. Her ADAMTS13 level was normal, effectively excluding thrombotic thrombocytopenic purpura. Within 2 weeks of treatment her haematological parameters improved, and her renal function began to recover and within 2 months she became dialysis independent. Conclusion: This case highlights the challenges of a timely diagnosis of P-aHUS from other pregnancy-related diseases. Although our patient is dialysis-independent, her risk of relapse remains high with subsequent pregnancies. Currently we are awaiting her genetic sequencing to complete her assessment for underlying mutations and are determining the safest approach to a future planned pregnancy.
    [Show full text]
  • Mixing Studies
    Welcome Jim DeMase, Senior National Technical Sales Manager Sunday March 19, 2017/CAMLT/Kaiser Regional Reference Lab Welcome Your Presenter Today Jim DeMase, Senior National Technical Sales Manager, Precision BioLogic Account Manger for Western and Central USA and British Columbia, Alberta, Saskatchewan and Manitoba CANADA. H A L L A Hemostasis Is Unique-The Cascade, the Diseases and the Tests-All Mixed Up Part 1- What is Hemostasis Part 2- Intro to Hemophilia Part 3- Mixing Studies Objectives 1. Describe the stages of hemostasis as well as common bleeding and thrombotic disorders. 2. Explain the types of hemophilia, symptoms, diagnosis and common treatments. 3. Relate the methods and clinical application for a mixing study and the steps to perform one. What is Hemostasis? Pathology Study of diseases Especially the structural and functional changes (to the body) caused by the diseases Many disciplines Biochemistry Blood Transfusion Services Histology Microbiology Hematology Hematology Science of blood and its diseases Sub-disciplines: Immunology Microscopy Molecular Biology Hemostasis (Coagulation) Hemostasis The process of stopping bleeding Greek roots heme, blood + stasis, halt = halt of the blood Blood Red viscous liquid in arteries, veins and capillaries Pumped by the heart Irrigates every tissue Transport of gases, nutritive materials and elements for immunity Blood Leading the way in experimental and clinical research in hematology Blood composition Cellular Red cells: hemoglobin White cells: neutrophils, monocytes, lymphocytes Platelets: small cells, essential role in prevention of blood loss Liquid Plasma: yellow liquid, composed mainly of lightly salted water containing nutritional materials, waste products and numerous different proteins Proteins in the Plasma Albumin Globulins Coagulation proteins Procoagulant (e.g.
    [Show full text]
  • Outpatient Laboratory Requisition
    Yale-New Haven Hospital Department of Laboratory Medicine Outpatient Laboratory Requisition 20 York Street, New Haven, Connecticut 06510-3202 · 203-688-3670 · 1-800-305-3278 DATE: _____/____/_____ Unit #___________________________ Visit #_______________________________ Patient Name _______________________________________________________________________________ (Last, First, Middle Initial) Date of Birth______/_____/______ ❑ Female ❑ Male Patient Telephone: (______) ________-_____________ Address ___________________________________________________________________________________ (Street, City, State, Zip) ❑ Mr. Insured’s Name ❑ M r s . _______________________________________________________________________ Ms. Insured’s I.D. # __❑____________________________________________________________________________ Payor Number ______________________________________________________________________________ Primary Insurance: Name & State _______________________________________________________________ Relationship to patient: ❑ Self ❑ Spouse ❑ Child ❑ Other __________________________________________ Group # _________________________________ Insured’s Employer ________________________________ Diagnosis / ICD 9 Code _________________________ TIME DRAWN: ________ ❑ YNHH Blood Draw ❑ Fasting Specimen Type: ❑ Blood ❑ Urine ❑ Other_______________________ ❑ CSF ❑ Fluid____________ ❑ Bone Marrow ❑ Call / ❑ Fax Results ❑ Timed Urine Date Collected _______ Time Collected ________ To:________________________________ CC: X TEST NAME SCC CODE X TEST NAME SCC CODE
    [Show full text]
  • Pt Mixing Studies
    Lab Dept: Coagulation Test Name: PT MIXING STUDIES General Information Lab Order Codes: PTM Synonyms: Protime Mixing Study; Prothrombin Time Mixing Study; Simple PT Mixing Study CPT Codes: 85611 - Prothrombin time: substitution, plasma fractions, each Test Includes: PT 1:2 dilution reported in seconds. Logistics Test Indications: Useful for detecting the presence/absence of an inhibitor or the absence of specific coagulation factors. Lab Testing Sections: Coagulation Phone Numbers: MIN Lab: 612-813-6280 STP Lab: 651-220-6550 Test Availability: Daily, 24 hours Turnaround Time: 4 hours Special Instructions: ● Patient’s with hematocrit levels >55% must have a special tube made to adjust for the hematocrit; contact the laboratory for special tube. ● Specimen must arrive within 30 minutes of collection. ● Indicate when specimen is drawn from a line or a heparin lock. Specimen Specimen Type: Whole blood Container: Light Blue top tube (Buffered Na Citrate 3.2%) Draw Volume: 2.7 mL blood Processed Volume: 1 mL plasma Collection: ● A clean venipuncture is essential, avoid foaming. ● Entire sample must be collected with single collection, pooling of sample is unacceptable. ● Capillary collection is unacceptable. ● Patient’s with a hematocrit level >55% must have a special tube made to adjust for the hematocrit; contact lab for a special tube. ● Mix thoroughly by gentle inversion. Deliver immediately to the laboratory at room temperature via courier or pneumatic tube. Off campus collections: ● Must be tested within 4 hours. ● Do not refrigerate. ● If not received in our lab within 4 hours of collection, sample must be centrifuged and *platelet-poor plasma removed from cells and transferred to an aliquot tube being careful not to disturb the cell layer.
    [Show full text]
  • Mixing Study
    Improving Acute Care Using Coagulation Mixing Studies George A Fritsma MS, MLS The Fritsma Factor, Your interactive Hemostasis Resource℠ Sponsored by Precision BioLogic Dartmouth, Nova Scotia [email protected] www.fritsmafactor.com 1 Surgeons and physicians order PT and PTT assays to predict bleeding risk, often generating isolated, unexplained prolonged PTs or PTTs. In follow-up, the laboratory practitioner mixes patient plasma with normal plasma and repeats the assay. Mixing studies may be provided at community hospitals and acute care facilities. The information gained from mixing studies is an essential first step in the diagnosis of many hemostatic abnormalities. During this presentation, we discuss the importance of mixing studies, describe how they are performed, and show how their results contribute to the diagnosis. 2 Bottom Line at the Start (BLAST) The participant… • Lists the clinical applications for a PTT mixing study. • Lists the steps to perform a PTT mixing study. • Explains why the mixing study is an acute care assay. • Correlates mixing study results with lupus anticoagulant and specific inhibitor testing. 3 Mixing Study: An Acute Care Assay Differentiates a coagulopathy from a specific inhibitor or from a lupus anticoagulant + = Kershaw GK, Orellana D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thrombos Hemost 2013;39:283–90. 4 Case: 32-yo Female Pre-op Screen • Six weeks post-partum • Easy bruising, frequent nosebleeds,
    [Show full text]
  • Blood Coagulation Overview and Inherited Hemorrhagic Disorders 2002 Abshire
    Blood Coagulation Overview and Inherited Hemorrhagic Disorders 2002 Abshire 1) Thrombin is one of the key proteins in the coagulation cascade and has both procoagulant and anticoagulant properties. Which one of the following is an important anticoagulation function: a. Activation of factors V and VIII b. Factor XIII activation c. Stimulation of the thrombin activated fibrinolytic inhibitor (TAFI) d. Complex with thrombomodulin (TM). 2) The endothelial cell lining blood vessels possesses several important anticoagulation functions . Which one of the following is one of its' important hemostasis (procoagulant) functions? a. Production of nitric oxide (NO) b. Activation of thrombomodulin (TM) c. Release of plasminogen activator inhibitor (PAI-I) d. Release of TPA e. Interaction of heparin sulfate with anti-thrombin III (AT III) 3) A term well infant is born without complications after a normal pregnancy and initial nursery stay. Upon drawing the metabolic screen, the baby is noted to have prolonged oozing from the heelstick sample. CBC, plt ct, PT, a PTT and fibrinogen were normal. Family history is negative. He returns for the 2 week check and the mother notices that the umbilical cord has been oozing for 4 days. A screening test for factor XIII deficiency is ordered and the baby's clot does not dissolve in 5 M urea. The euglobulin lysis time (ELT) was less than one hour. The most likely diagnosis is: a. Factor XIII heterozygous deficiency b. Homozygous antiplasmin deficiency c. Mild hemophilia B (Factor IX deficiency) d. von Willebrand Disease e. Tissue plasminogen activator (TPA) excess. 4) The newborn's coagulation system is both similar and quite different from a child's.
    [Show full text]
  • Elevated APTT? How Best to Follow Up
    Online ExClusivE Habib Ur Rehman, MBBS, FACP, FRCPC Elevated APTT? Department of Medicine, Regina General Hospital, How best to follow up Saskatchewan, Canada [email protected] This step-by-step guide will help you refine The author reported no potential conflict of interest your approach to an abnormal activated partial relevant to this article. thromboplastin time. CASE u During an office visit, 23-year-old CASE u mr. K’s physical examination is un- john K tells you that he recently experienced remarkable and his renal and liver panel— excessive bleeding after a dental extraction. including serum albumin—are within the he says that he has no personal or family his- normal range. as noted earlier, he had no tory of a bleeding disorder and is not taking history of bleeding before the tooth extrac- any medication that might have contributed tion; his family history is negative for excessive to the problem. bleeding, as well. his lab work shows a normal complete blood count and international normalized ratio (inr). his activated partial thrombo- Consider an artifactual cause plastin time (apTT), however, is 67 seconds It’s important to rule out artifactual causes (normal=24-37 seconds). of an abnormal APTT before undertaking a how would you manage his care? more detailed investigation. Although not applicable in this case, unfractionated hepa- orrect interpretation of abnormal rin in a central venous or arterial catheter can APTT readings requires an under- prolong APTT. C standing of the clinical context in z A high hematocrit value will give which the test is ordered and the test’s limita- falsely prolonged APTT.
    [Show full text]
  • Charge Master
    Epic Charge Code Description Epic Price HC PBB FNA BIOPSY W/O IMAGE GUIDE EA ADDL LESION $587.00 HC FNA BIOPSY W/US GUIDANCE 1ST LESION $1,540.00 HC FNA BIOPSY W/US GUIDANCE EA ADDL LESION $610.25 HC FNA BIOPSY W/FLUORO GUIDANCE 1ST LESION $1,540.00 HC FNA BIOPSY W/FLUORO GUIDANCE EA ADDL LESION $610.25 HC FNA BIOPSY W/CT GUIDANCE 1ST LESION $1,540.00 HC FNA BIOPSY W/CT GUIDANCE EA ADDL LESION $610.25 HC FNA BIOPSY W/MR GUIDANCE 1ST LESION $1,540.00 HC FNA BIOPSY W/MR GUIDANCE EA ADDL LESION $610.25 HC FNA BIOPSY W/O IMAGE GUIDE 1ST LESION $788.00 HC IMAGE-GUIDED CATHETER FLUID COLLECTION DRAINAGE $1,205.50 HC PERQ SFT TISS LOC DEVICE PLMT 1ST LES W/GDNCE $3,652.00 HC PLACEMENT SOFT TISSUE LOCALIZATION DEVICE PERQ EA ADDL W/IMAGE $1,995.00 HC PBB ACNE SURGERY $597.00 HC DRAIN SKIN ABSCESS SIMPLE $441.00 HC DRAIN SKIN ABSCESS COMPLIC $842.75 HC DRAIN PILONIDAL CYST SIMPL $1,552.75 HC REMOVE FOREIGN BODY SIMPLE $842.75 HC REMOVE FOREIGN BODY COMPLIC $1,945.00 HC DRAINAGE OF HEMATOMA/FLUID $1,945.00 HC PUNCTURE DRAINAGE OF LESION $842.75 HC COMPLEX DRAINAGE, WOUND $3,148.75 HC DEBRIDEMENT, INFECTED SKIN, UP TO 10% BSA $1,127.00 HC DEBRIDE ASSOC OPEN FX/DISLO SKIN/MUS/BONE $2,717.50 HC DEBRIDEMENT, SKIN, SUB-Q TISSUE,=<20 SQ CM $938.75 HC DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,=<20 SQ CM $1,453.65 HC DEBRIDEMENT BONE 1ST </=20 SQ CM $2,650.00 HC DEBRIDEMENT, SKIN, SUB-Q TISSUE,EACH ADD 20 SQ CM $469.50 HC DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,EACH ADD 20 SQ CM $726.80 HC DEBRIDEMENT, SKIN, SUB-Q TISSUE,MUSCLE,BONE,EACH ADD 20 SQ CM $1,450.00
    [Show full text]
  • Reflex Test Protocols 2016
    MGH Pathology Service Laboratory Reflex Test Protocols 2016 Reflex Test Protocols Reflex tests fall into 2 categories: standard industry practice (example: sensitivities, interpretations, and confirmations) and institutional practice based on staff clinical practice Tests that are reflexed should be reasonable and medically necessary. The medical community should approve reflex protocols. The physician must have the option of selecting a reflex protocol or a single test. Blood Transfusion Services Test ordered on Requisition Initial Test Performed Criteria for Reflex Test Ordered by Reflex Antibody Screen Antibody Screen Positive screen Antibody identification Cold agglutinin screen Cold agglutinin screen Positive (>1+) Cold agglutinin titer Direct antiglobulin test Direct antiglobulin test IgG positive and transfused w/in 3 Eluate mo Fetal Screen Fetal screen Positive Kleihauer-Betke Core Lab - Chemistry Test ordered on Requisition Initial Test Performed Criteria for Reflex Test Ordered by Reflex Thyroid Screen TSH TSH>5.00 Free T4 TSH<0.40 Free T4. T3 Monitoring L-T4 Therapy TSH TSH<0.05 Free T4 Thyroglobulin Thyroglobulin Specimen received and test Thyroglobulin Antibodies requested Direct LDL Lipid Panel with calculated LDL Triglycerides >399 Direct (measured LDL) Free testosterone Total testosterone, sex hormone Albumin <3.5 Free testosterone measured by binding globulin (SHBG), albumin, equilibrium dialysis free testosterone (calculated), % free testosterone (calculated). Notes: The albumin is needed for the calculation but will
    [Show full text]